Media Centre
News
Media Relations
Publications and Magazines
JGH TV
Contact Us

News from the JGH 
 
Back to full list
2017/01/26
Number of people with Alzheimer’s disease world-wide will double between 2030 and 2050

Alzheimer’s Disease Awareness Month

Press Release

Montreal, January 26, 2017– Research to fight Alzheimer’s disease is continuing relentlessly in the hope that an effective treatment will be found to help the 110,000 people affected in Quebec. “Detecting the cause of the disease remains the number one challenge," says Dr. Andréa C. LeBlanc, Manager of the research laboratory at the Bloomfield Centre on Research in Aging at the Lady Davis Institute at the Jewish General Hospital (JGH). In the following video, Dr. LeBlanc adds, “We expect to see this number double between 2030 and 2050.”

Alzheimer’s disease is characterized by an alteration in cognition, caused by progressive cell degeneration in a particular area of the brain. Behaviour and emotions can also be affected as the disease progresses.

“We are extremely lucky to be able to count on the support of the JGH Foundation, which allows us to push a little further every day," adds Dr. LeBlanc. “With an aging world-wide population, the stakes are crucial. It’s a race against time."

More than ever, research is fundamental to controlling the disease. The earlier that Alzheimer’s disease is diagnosed, the greater is our potential to preserve the quality of an individual’s life.

"In addition to the tragic, personal toll of Alzheimer's disease, it has been estimated that the illness costs Canadians approximately $10 billion a year," says Dr. Lawrence Rosenberg, President and CEO of CIUSSS West-Central Montreal. "Our healthcare network is proud to be playing a significant role—through prevention, treatment, care, research and education—in helping individuals cope with Alzheimer's, while working toward a cure for this debilitating disease.

"A key element in this battle is the Canadian Consortium on Neurodegeneration in Aging, a nation-wide network of scientists that is based at the Lady Davis Institute and is led by Dr. Howard Chertkow, co-founder of the JGH/McGill Memory Clinic. These researchers are making a unified effort to find a way of preventing or delaying the onset of dementia and related illnesses, while improving the lives of those who are ill and their caregivers."

Alzheimer’s disease by the numbers:

  • 110,000 people with the disease in Quebec 
  • 564,000 people with the disease in Canada 
  • 46 million people— more than the population of Canada—with the disease world-wide

 


Media Relations: Emmanuelle Paciullo | epaciullo@jgh.mcgill.ca | 514 340-8222, ext. 4120 | Pager: 514-413-1289
CIUSSS West-Central Montreal: serving a population of nearly 345,000, more than 9,000 employees including 900 doctors.